benzamide adenine nucleotide has been researched along with Acute Lymphoid Leukemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abali, EE; Banerjee, D; Bertino, JR; Felczak, K; Gounder, M; Johnson-Farley, N; Kerrigan, JE; Lin, H; Pankiewicz, KW; Roussel, B; Scotto, KW | 1 |
1 other study(ies) available for benzamide adenine nucleotide and Acute Lymphoid Leukemia
Article | Year |
---|---|
A second target of benzamide riboside: dihydrofolate reductase.
Topics: Adenine Nucleotides; Benzamides; Cell Line, Tumor; Down-Regulation; Drug Resistance, Neoplasm; Humans; IMP Dehydrogenase; Methotrexate; Molecular Targeted Therapy; NADP; Nucleosides; Phosphotransferases (Alcohol Group Acceptor); Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tetrahydrofolate Dehydrogenase | 2012 |